MENU

Investor Relations

everything you need to make informed investment decisions

recent releases
View all
Apr 01, 2024
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

Press release

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market -Advanced regulatory and seed scale-up program for omega-3 Camelina -E3902 oil trait in Camelina cleared by regulatory authority for planting in Canada -Management will host a conference call today at

Keep reading arrow-right
events & presentations
View all
Apr 1, 2024 4:30 PM EDT
Yield10 Bioscience Fourth Quarter 2023 Earnings Call
Listen to webcast
Mar 14, 2024
ABLC 2024 Presentation by Kristi Snell
Dec 5, 2023
Canola Week 2023 Presentation by Meghna Malik
recent sec filings
View all
 

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
external link icon

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
external link icon

Statement of changes in beneficial ownership of securities

4
external link icon

Statement of changes in beneficial ownership of securities

4
external link icon
quarterly results
View all
Printed Materials
Email Alerts
Download Library
RSS News Feeds